Home > 

EXECUTING EXPLORATORY CLINICAL DEVELOPMENT STUDIES

Getting a better understanding of the pharmacology of a candidate drug at an early stage of the drug development is thought to improve the prediction of the efficacy of a new drug. Exploratory clinical trials are now a true opportunity which brings more and earlier pharmacology data to make better go no-go decisions before the conventional FIH/Phase 1 approach.

Read the full article by filling out the form below.

Information Request
Company name*:
Last name*:
First name*:
E-mail*:
Phone:
Country*:
Comments:
 
* indicates a required field  

I understand that by clicking on the Send button, I accept the Terms of Access and am satisfied with the Privacy Policy.
SEND